Sylvain Vigneault is the Country Manager for Viatris ANZ. Throughout 2020-2021, Sylvain guided the business through the transition to Viatris, which was formed through the combination of Mylan and Upjohn, a legacy division of Pfizer at the height of the COVID-19 pandemic. Prior to this appointment, Sylvain held the role of Country Manager for Australia and Head of Commercial for New Zealand at Mylan for almost six years, following Mylan’s acquisition of Abbott EPD in 2015.

Sylvain’s career began in Canada and he has held sales, marketing and senior management roles in Czech Republic, France, Germany, Switzerland and Singapore before coming to Australia in 2012 as General Manager Australia & New Zealand for Abbott EPD. From March 2018 to October 2020, Sylvain held the role of Chair of the Generic and Biosimilar Medicines Association.

Session details: Unlocking opportunities in down-scheduling and pharmacist prescribing | Thursday 20 March 2025 | 2.50pm – 3.35pm